Collection highlight from @Cancer_Cell: Mutant KRAS peptide targeted CAR-T cells engineered for cancer therapy hubs.li/Q03x0gSB0 @PennMedicine
Conventional proteomics searches struggle with many modifications and open searches may be difficult to interpret. We introduce a "detailed" mass offset search in #MSFragger boosting interpretability and localization especially in complex cases like FPOP: biorxiv.org/content/10.110…
We recently received notice that the federal government is suspending certain research funding to @UCLA. This is not just a loss for our faculty and researchers. It’s a loss for the people across the country who rely on the breakthroughs and innovations that begin right here.
With boost to NIH budget, Senate panel rejects Trump’s plan to slash agency | Science | AAAS science.org/content/articl…
Meet the early career scientists planning to leave the United States nature.com/articles/d4158…
Just came across a fantastic article covering our work on moPepGen — truly honored by the thoughtful writing and high praise. Grateful to see our efforts in advancing proteogenomics recognized like this. forwardpathway.us/mopepgen-a-new…
The algorithm unlocks the full potential of proteogenomics by overcoming a key challenge in linking genetic mutations to protein-level changes. @dgsomucla @UCLAHealthJCCC newsroom.ucla.edu/stories/new-co…
Proteogenomics algorithm improves the detection of hidden genetic mutations #NBTIntheNews via @GENbio genengnews.com/topics/artific…
checkout our latest paper in @NatureBiotech. We developed a graph-based algorithm that comprehensively generates non-canonical peptides in linear time. nature.com/articles/s4158…
Identification of non-canonical peptides with moPepGen go.nature.com/3HYJyyz
Our paper on moPepGen is finally out in Nature Biotechnology! moPepGen is a fast graph-based tool for systematically predicting and detecting non-canonical peptides, revealing the “dark side” of the proteome. Hoping it opens new doors in proteogenomics. nature.com/articles/s4158…
T Cell Responses to Individualized Neoantigen Therapy mRNA-4157 (V940) +/- Pembrolizumab (KEYNOTE-603). @CD_AACR. 🚨@OncoAlert 🏥 Phase I, resected #NSCLC & #melanoma 💊No grade 4/5 AEs ✅Neoantigen-specific T cell responses and expansion after combo doi.org/10.1158/2159-8…
Site-Specific Glycoprofiles of HDL-Associated ApoE are Correlated with HDL Functional Capacity and Unaffected by Short-Term Diet #JProteomeRes #MassSpec pubs.acs.org/doi/10.1021/ac…
United States 趨勢
- 1. Good Thursday 26.7K posts
- 2. Happy Friday Eve N/A
- 3. #thursdaymotivation 1,607 posts
- 4. #thursdayvibes 2,238 posts
- 5. #ThursdayThoughts 1,541 posts
- 6. #หลิงออมปฏิทินช่อง3ปี2569 720K posts
- 7. LINGORM CH3 CALENDAR SIGN 714K posts
- 8. Nnamdi Kanu 61.5K posts
- 9. #ProofOfFortification N/A
- 10. FEMA 79.6K posts
- 11. Crockett 58.5K posts
- 12. But Jesus 21.8K posts
- 13. The 2024 87.8K posts
- 14. NO CAP 14.4K posts
- 15. Knicks 14.1K posts
- 16. Shamet 3,183 posts
- 17. Sam Harris 3,879 posts
- 18. Paint 32.4K posts
- 19. FREE HAT 1,877 posts
- 20. GM CT 23.4K posts
Something went wrong.
Something went wrong.